Vermont has one of the highest rates of mental health need in the country, paired with one of the most geographically dispersed populations — a combination that makes access to specialized psychiatric care a persistent and real challenge for many residents. At Taconic Psychiatry in Manchester, Vermont, we recognize that requiring every patient to travel to our clinic for every session of ketamine treatment creates a barrier that some people simply cannot overcome, particularly during the intensive early phase of treatment. At-home ketamine therapy exists specifically to address this gap — and understanding what it involves, what safeguards it includes, and who it is appropriate for helps patients make informed decisions about whether it is the right option for them.
What At-Home Ketamine Therapy Is
At-home ketamine therapy involves administering ketamine outside a clinical setting — typically using oral troches (dissolvable tablets), sublingual preparations, or intranasal formulations — under the remote supervision of a licensed prescriber. At Taconic Psychiatry, our at-home ketamine protocols are designed with the same clinical rigor we apply to in-office treatment. Patients are thoroughly evaluated before receiving a prescription, and sessions are conducted with telehealth check-ins to ensure appropriate oversight throughout the treatment course.
The medications used in at-home protocols are different from IV ketamine. Oral and sublingual ketamine has lower and more variable bioavailability than the IV route, meaning the dose that reaches the bloodstream is less predictable and typically less concentrated. This is not a flaw — it is a clinical characteristic that makes at-home administration more appropriate for certain patient profiles and clinical goals. For some patients, oral ketamine serves as a maintenance tool to extend the gains made during an initial in-office treatment series. For others, particularly those with moderate depression who are earlier in the treatment-resistance spectrum, at-home protocols may represent an appropriate first step.
We want to be direct about what at-home ketamine is not: it is not a self-directed, unsupervised experience. Every patient in our at-home protocol is evaluated and medically cleared before beginning, receives specific preparation and guidance from our clinical team, and has structured oversight throughout the course of treatment. Adam Pruett, MD, MPH, and our clinical team review each patient’s response and adjust protocols as needed. This is a medical treatment with clinical supervision — not a consumer product.
How At-Home Ketamine Fits the Vermont Context
Vermont is a state where traveling an hour or more for a medical appointment is a commonplace reality, not an exceptional circumstance. During the induction phase of an in-office ketamine protocol — which typically involves multiple sessions per week — that travel burden can become prohibitive. At-home ketamine offers an alternative pathway that does not require the same logistical infrastructure.
This flexibility is also relevant for patients who have responded well to an initial in-office ketamine series but want to maintain the gains they have made without committing to ongoing in-person visits. A maintenance at-home protocol, managed by our clinical team with regular telemedicine psychiatry services, can provide the sustained neurobiological support that helps prevent relapse without requiring each patient to build their entire schedule around clinic travel.
At the same time, we do not position at-home ketamine as a replacement for IV ketamine in all situations. For patients with more severe or entrenched treatment-resistant depression, or for those who have specific clinical risk factors that warrant closer monitoring, in-office treatment — whether IV ketamine or intramuscular ketamine — remains the more appropriate choice. We discuss this distinction clearly during every consultation, and we help patients identify which modality aligns with their clinical situation. Results vary by individual, and the right protocol is always individualized.
Two Barriers Patients Raise About At-Home Ketamine
The first barrier is concern about safety — specifically, whether it is responsible to administer a psychoactive medication without a provider physically present. This concern reflects a genuine and reasonable instinct, and we want to address it with specificity. At Taconic Psychiatry, at-home ketamine is prescribed only after a comprehensive clinical evaluation that screens for contraindications, establishes appropriate dosing, and assesses a patient’s capacity to manage the experience safely at home. Every patient receives detailed preparation: what to expect during the session, how to create a safe physical environment, and when to contact us. We require a trusted support person to be present or available during sessions for patients in our at-home program. Telehealth integration means our team is accessible throughout the treatment course.
The second barrier is uncertainty about whether at-home ketamine actually works as well as in-office treatment. The honest answer is that the evidence varies by delivery route and clinical indication. Oral ketamine has a different bioavailability profile than IV ketamine, and for the highest levels of treatment resistance, in-office IV administration generally produces stronger acute effects. For moderate presentations, maintenance use, or as a complement to an initial in-office series, the evidence for at-home protocols is meaningful and supported by a growing clinical experience base. Our blog post on the benefits of at-home ketamine therapy explores this evidence in more depth. Discuss with your provider which approach is most appropriate for your specific presentation and treatment history.
FAQ
Who is a good candidate for at-home ketamine at Taconic Psychiatry?
At-home ketamine may be appropriate for patients with moderate treatment-resistant depression, those using it as a maintenance protocol after completing an in-office series, or those for whom travel logistics to our Manchester clinic present a significant barrier. A thorough clinical evaluation is required before any at-home prescription. Patients with more severe presentations or specific medical contraindications typically need in-office treatment.
What does an at-home ketamine session involve?
Patients receive oral or sublingual ketamine preparations, specific preparation guidance from our team, and telehealth support throughout the treatment course. Sessions are conducted in a safe, prepared environment with a trusted support person available. Results vary by individual.
Is at-home ketamine the same as IV ketamine?
No. At-home protocols use oral or sublingual preparations with different bioavailability profiles than IV administration. IV ketamine produces more predictable and typically more robust acute effects. The clinical indications for each modality differ, and the right choice depends on your specific situation.
How does Taconic Psychiatry monitor patients during at-home treatment?
We integrate telehealth check-ins throughout the at-home treatment course. Patients have clear guidance on what to monitor, when to contact the clinic, and how to manage any unexpected effects. Our team reviews each patient’s response and adjusts protocols as needed.
Can I switch from at-home ketamine to in-office treatment if needed?
Yes. Our clinical approach is responsive to how you are doing. If your at-home protocol is not producing adequate benefit, or if your clinical situation changes, we can transition you to in-office IV or IM ketamine as appropriate. We consider the full range of options available at our practice.
Key Takeaways
- At-home ketamine therapy uses oral or sublingual preparations administered outside the clinic under telehealth supervision — not self-directed, unsupervised use.
- It is particularly relevant for Vermont patients facing significant travel logistics and for those maintaining gains from an initial in-office ketamine series.
- At Taconic Psychiatry, at-home ketamine is prescribed only after thorough clinical evaluation and includes structured telehealth oversight throughout the treatment course.
- At-home protocols have different bioavailability characteristics than IV ketamine and are most appropriate for specific clinical profiles — not all patients.
- Results vary by individual; discuss with your provider whether at-home ketamine aligns with your clinical situation and goals.
Conclusion
Access to mental health care should not be determined by whether someone can travel an hour each way several times a week. At Taconic Psychiatry, at-home ketamine therapy is one of the ways we have worked to make effective treatment available to Vermont patients across the logistical realities of rural life in this state — without compromising the clinical oversight that makes the treatment safe. If you are in Vermont and want to explore whether at-home ketamine is an appropriate option for you, we invite you to schedule a consultation with our team. Discuss with your provider what the right modality looks like for your specific situation — and let us help you find a path that works.
About Adam Pruett, MD, MPH
Adam Pruett, MD, MPH graduated from Birmingham-Southern College magna cum laude with a BA in German. He completed medical school at the University of Alabama and his residency at Emory University, where he served as chief resident at Grady Hospital, playing an instrumental role in teaching and supervising new doctors. For over 10 years, Dr. Pruett worked primarily in an inpatient psychiatric setting in Alabama and Vermont. He completed an immersive year-long fellowship with the Integrative Psychiatry Institute, focusing on integrative psychiatry — a form of care that looks to resolve the underlying causes of mental illness rather than simply reducing symptoms. He co-founded Taconic Psychiatry in Manchester, Vermont with his colleague Dr. Ben Stillman. The practice offers integrative psychiatry alongside clinical psychologists specializing in cognitive-behavioral, ERP, and psychodynamic psychotherapy, as well as at-home ketamine protocols and in-office intramuscular ketamine treatment.
References
National Institute of Mental Health — https://www.nimh.nih.gov/health/topics/depression
American Society of Ketamine Physicians, Psychotherapists & Practitioners — https://www.askp3.org/
Vermont Department of Health, Mental Health Services — https://www.healthvermont.gov/wellness/mental-health
Integrative Psychiatry Institute — https://www.psychiatryinstitute.com/
Medical Disclaimer
The content on this page is provided by Taconic Psychiatry for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Ketamine therapy, including at-home protocols, for psychiatric conditions is an off-label use of an FDA-approved anesthetic. Results vary by individual. This content should not replace consultation with a qualified healthcare provider. Please discuss with your provider whether at-home ketamine therapy is appropriate for your specific medical history and clinical needs.